United States · FDA National Drug Code directory
Heparin Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-540_e59b46ab-12ac-4ae9-bd13-3146984037e0
- Product NDC
- 63323-540
- Form
- INJECTION, SOLUTION
- Composition / generic term
- HEPARIN SODIUM
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20191104
- Source listing expiry
- 20271231
Source-listed ingredients
- HEPARIN SODIUM — 1000 [USP'U]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 TRAY (63323-540-13) / 1 mL in 1 VIAL (63323-540-03) · 63323-540-13
- 25 VIAL in 1 TRAY (63323-540-15) / 10 mL in 1 VIAL (63323-540-05) · 63323-540-15
- 25 VIAL in 1 TRAY (63323-540-36) / 30 mL in 1 VIAL (63323-540-33) · 63323-540-36
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →